Vaccines to halt the spread of COVID-19 have been trialed in human patients for the first time, but experts suggest they are still a year away.

COVID-19, the potentially fatal respiratory illness first detected in December 2019, has spread across the globe, forcing the cancellation of major events, postponing sports seasons, and sending many into self-imposed quarantine and self-isolation. Health authorities and governments are attempting to flatten the curve, mitigating the spread through the community, while scientists and biotech firms turn their attention to the coronavirus causing the disease: SARS-CoV-2.

Since it was first discovered as the causative agent of the new disease, scientists have been racing to get a better understanding of the virus’ genetic makeup, how it infects cells and how to effectively treat it. Currently there’s no cure, and medical specialists can only treat the symptoms of the disease. However, the long-term strategy to combat COVID-19, which has spread to every continent on Earth besides Antarctica, will be to develop a vaccine.

Developing new vaccines takes time, and they must be rigorously tested and confirmed safe via clinical trials before they can be routinely used in humans. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases in the US, has frequently stated that a vaccine is at least a year to 18 months away. Experts agree there’s a ways to go yet.

Vaccines are incredibly important in the fight against disease. We’ve been able to keep a handful of viral diseases at bay for decades because of vaccine development. Even so, there exists confusion and unease about their usefulness. This guide explains what vaccines are, why they are so important and how scientists will use them in the fight against the coronavirus. As more candidates appear and are tested, we’ll add them to this list, so bookmark this page and check back for the latest updates.

What is a vaccine?

A vaccine is a type of treatment aimed at stimulating the body’s immune system to fight against infectious pathogens, like bacteria and viruses. They are, according to the World Health Organization, “one of the most effective ways to prevent diseases.”

The human body is particularly resilient to disease, having evolved a natural defense system against nasty disease-causing microorganisms like bacteria and viruses. The defense system — our immune system — is composed of different types of white blood cells that can detect and destroy foreign invaders. Some gobble up bacteria, some produce antibodies which can tell the body what to destroy and take out the germs, and other cells memorize what the invaders look like, so the body can respond quickly if they invade again.

Vaccines are a really clever fake-out. They make the body think it’s infected so it stimulates this immune response. For instance, the measles vaccine tricks the body into thinking it has measles. When you are vaccinated for measles, your body generates a record of the measles virus. If you come into contact with it in the future, the body’s immune system is primed and ready to beat it back before you can get sick.

The very first vaccine was developed by a scientist named Edward Jenner in the late 18th century. In a famous experiment, Jenner scraped pus from a milkmaid with cowpox — a type of virus that causes disease mostly in cows and is very similar to the smallpox virus — and introduced the pus into a young boy. The young boy became a little ill and had a mild case of cowpox. Later, Jenner inoculated the boy with smallpox, but he didn’t get sick. Jenner’s first injection of cowpox pus trained the boy’s body to recognize the cowpox virus and, because it’s so similar to smallpox, the young man was able to fight it off and not get sick.

Vaccines have come an incredibly long way since 1796. Scientists certainly don’t inject pus from patients into other patients, and vaccines must abide by strict safety regulations, multiple rounds of clinical testing and strong governmental guidelines before they can be adopted for widespread use.

What’s in a vaccine?

Vaccines contain a handful of different ingredients depending on their type and how they aim to generate an immune response. However, there’s some commonality between them all.

The most important ingredient is the antigen. This is the part of the vaccine the body can recognize as foreign. Depending on the type of vaccine, an antigen could be molecules from viruses like a strand of DNA or a protein. It could instead be weakened versions of live viruses. For instance, the measles vaccine contains a weakened version of the measles virus. When a patient receives the measles vaccine, their immune system recognizes a protein present on the measles virus and learns to fight it off.

A second important ingredient is the adjuvant. An adjuvant works to amplify the immune response to an antigen. Whether a vaccine contains an adjuvant depends on the type of vaccine it is.

Some vaccines used to be stored in vials that could be used multiple times and, as such, contained preservatives that ensured they would be able to sit on a shelf without growing other nasty bacteria inside them. One such preservative is thimerosal, which has garnered a lot of attention because it contains trace amounts of easily cleared ethylmercury. Its inclusion in vaccines hasn’t been shown to cause harm, according to the CDC. In places like Australia, single-use vials are now common, and thus preservatives such as thimerosal are no longer necessary in most vaccines.

In developing a vaccine for SARS-CoV-2, scientists need to find a viable antigen that will stimulate the body’s immune system into defending against infection.

Making a COVID-19 vaccine

The pathogen at the center of the outbreak, SARS-CoV-2, belongs to the family of viruses known as coronaviruses. This family is so named because, under a microscope, they appear with crownlike projections on their surface.

In developing a vaccine that targets SARS-CoV-2, scientists are looking at these projections intensely. The projections enable the virus to enter human cells where it can replicate and make copies of itself. They’re known as “spike proteins” or “S” proteins. Researchers have been able to map the projections in 3D, and research suggests they could be a viable antigen in any coronavirus vaccine.

That’s because the S protein is prevalent in coronaviruses we’ve battled in the past — including the one that caused the SARS outbreak in China in 2002-03. This has given researchers a head start on building vaccines against part of the S protein and, using animal models, they’ve demonstrated they can generate an immune response.

There are many companies across the world working on a SARS-CoV-2 vaccine, developing different ways to stimulate the immune system. Some of the most talked about approaches are those using a relatively novel type of vaccine known as a “nucleic acid vaccine.” These vaccines are essentially programmable, containing a small piece of genetic code to act as the antigen.

Biotech companies like Moderna have been able to generate new vaccine designs against SARS-CoV-2 rapidly by taking a piece of the genetic code for the S protein and fusing it with fatty nanoparticles that can be injected into the body. Imperial College London is designing a similar vaccine using coronavirus RNA — its genetic code. Pennsylvania biotech company Inovio is generating strands of DNA it hopes will stimulate an immune response. Although these kinds of vaccines can be created quickly, none have been brought to market yet.

Johnson & Johnson and French pharmaceutical giant Sanofi are both working with the US Biomedical Advanced Research and Development Authority to develop vaccines of their own. Sanofi’s plan is to mix coronavirus DNA with genetic material from a harmless virus, whereas Johnson & Johnson will attempt to deactivate SARS-CoV-2, essentially switching off its ability to cause illness while ensuring it still stimulates the immune system.

Some research organizations, such as Boston Children’s Hospital, are examining different kinds of adjuvants that will help amplify the immune response. This approach, according to the Harvard Gazette, will be targeted more toward the elderly, who don’t respond as effectively when vaccinated. It’s hoped that by studying adjuvants to boost a vaccine, the elderly can be vaccinated with a mix of ingredients that would supercharge their immunity.

When will a vaccine be available?

Fauci, of the infectious diseases institute, posits that a vaccine is roughly a year and a half away, even though we’re likely to see human trials start within the next month or two. This, according to a 60 Minutes interview with Fauci in March, is a fast turnaround.

“The good news is we did it more quickly than we’ve ever done it,” Fauci told 60 Minutes. (Note: 60 Minutes and CNET share a common parent company, ViacomCBS.) “The sobering news is that it’s not ready for prime time, for what we’re going through now.”

Why does vaccine production take so long? There are many steps involved and a lot of regulatory hurdles to jump through.

“For any medicine to be sold it needs to go through the standard process of clinical trials including phase 1 [to] 3 trials,” said Bruce Thompson, dean of health at Swinburne University in Australia. “We need to ensure that the medicine is safe, will not do harm, and know how effective it is.”

Scientists can’t assume their vaccine design will just work — they have to test, test and test again. They have to recruit thousands of people to ensure the safety of a vaccine and how useful it will be. The process can be broken down into six phases:

  • Vaccine design: Scientists study a pathogen and decide on how they will get the immune system to recognize it.
  • Animal studies: A new vaccine is tested in animal models for disease to show that it works and has no extreme adverse effects.
  • Clinical trials (phase I): These represent the first tests in human beings and test the safety, dose and side effects of a vaccine. These trials only enroll a small cohort of patients.
  • Clinical trials (phase II): This is a deeper analysis of how the drug or vaccine actually works biologically. It involves a larger cohort of patients and assesses the physiological responses and interactions with the treatment. For instance, a coronavirus trial may assess if a vaccine stimulates the immune system in a certain way.
  • Clinical trials (phase III): The final phase of trials sees an even greater amount of people tested over a long period of time.
  • Regulatory approval: The final hurdle sees regulatory agencies, like the US Food and Drug Administration, the European Medicines Agency and Australia’s Therapeutic Goods Administration, take a look at the available evidence from experiments and trials and conclude whether a vaccine should be given the all-clear as a treatment option.

Traditionally, then, it could take a decade or more for a new vaccine to go from design to approval. In addition, once the regulatory processes have concluded a vaccine is safe, the drug companies have to send production into overdrive, so they can manufacture enough of the vaccine to increase immunity in the wider population.

With SARS-CoV-2, the process is being expedited in some instances. As STATnews reports, the vaccine in development by Moderna has moved from design straight into Phase I clinical trials of its mRNA vaccine, skipping tests in animal models. Those tests will take place at Seattle’s Kaiser Permanente Washington Health Institute, and patients are now being enrolled.

First US COVID-19 vaccine trials in humans

In the US, Moderna’s Phase I clinical trials began on March 16 in collaboration with NIAID, the US National Institutes of Health and KPWHRI. It is the first testing in humans of the mRNA vaccine and will look to enroll a total of 45 healthy adult volunteers aged between 18 and 55 years.

“This Phase 1 study, launched in record speed, is an important first step toward achieving that goal,” Fauci said in a statement.

Moderna’s approach, explained in the Vaccines section above, is particularly unique in its speed. Because the biotech company was already researching ways to tackle the coronavirus which causes Middle East respiratory syndrome, they were able to adapt their methodology and vaccine design for SARS-CoV-2. The experimental vaccine, dubbed mRNA-1273, contains genetic material from the spike protein present in SARS-CoV-2 embedded within a lipid nanoparticle.

Manufacturing costs were supported by the Coalition for the Epidemic Preparedness Innovations.

The trial will see patients receive two injections of the mRNA-1273 28 days apart. The 45 patients will be divided into three groups of 15 and given differing doses: Either 25 micrograms, 100 micrograms or 250 micrograms. Safety reviews will be performed after the first four patients receive the lowest and middle doses and again before all patients receive their shots. Another safety review of data will be performed before the 15 patients set to receive the highest dose are a injected.

Even if the vaccine is proven to be safe and shows promise in protecting against COVID-19, it could still be a year away — at least.

How do you treat COVID-19?

The best way to prevent illness is avoiding exposure. Those tips are below.

First: Antibiotics, medicine designed to fight bacteria, won’t work on SARS-CoV-2, a virus. If you’re infected, you will be asked to self-isolate, to prevent further spread of the disease, for 14 days. If symptoms escalate and you experience a shortness of breath, high fever and lethargy, you should seek medical care.

Treating cases of COVID-19 in the hospital is based on managing patient symptoms in the most appropriate way. For patients with severe disease adversely affecting the lungs, doctors place a tube into the airway so that they can be connected to ventilators — machines which help control breathing.

There are no specific treatments for COVID-19 as yet, though a number are in the works, including experimental antivirals, which can attack the virus, and existing drugs targeted at other viruses like HIV which have shown some promise in treating COVID-19.


Remdesivir, an experimental antiviral made by biotech firm Gilead Sciences, has garnered a large part of the limelight. The drug has been used in the US, China and Italy, but only on a “compassionate basis” — essentially, this drug hasn’t received approval but can be used outside of a clinical trial on critically ill patients. Remdesivir isn’t specifically designed to destroy SARS-CoV-2. Instead, it works by knocking out a specific piece of machinery in the virus, known as “RNA polymerase,” which many viruses use to replicate. It has been shown in the past to be effective in human cells and mouse models.

Its effectiveness is still being debated, and much more rigorous study will be needed before this becomes a general treatment for SARS-CoV-2, if it does at all. 


Encouraging clinical trials in Wuhan and Shenzhen involving over 300 patients of the Japanese influenza drug favipiravir were reported by Chinese scientists in the Guardian on March 18. The drug appeared to shorten the course of the disease, with patients who were given the treatment clearing the virus after just four days, while those who did not took around 11 days.

The drug is manufactured by Fujifilm Toyama Chemical, but the company has declined to comment on the claims. Favipiravir, also known as Avigan, is an antiviral and is designed to target RNA viruses which include coronaviruses and influenza viruses. The drug is thought to disrupt a pathway which helps these viruses to replicate inside cells. According to the Guardian, a source within the Japanese health ministry suggests the drug is not effective in patients showing severe symptoms.

Other treatment options

An HIV medicine, Kaletra/Aluvia, has been used in China to treat COVID-19. According to a release by AbbVie, an Illinois-based pharmaceutical company, the treatment was provided as an experimental option for Chinese patients during “the early days” of fighting the virus. The company suggests it is collaborating with global health authorities including the Centers for Disease Control and Prevention and the World Health Organization.

On March 18, a randomized, controlled trial assessed the effectiveness of the HIV medicine. The results, published in the New England Journal of Medicine, show that adults with severe COVID-19 infections do not seem to benefit from the drug treatment and there was no clinical improvement versus standard care. The authors note additional studies should be undertaken because the treatment may reduce serious complications — such as acute kidney injury or secondary infections — if given at a certain stage of illness.


A drug that has been used to treat malaria for around 70 years, chloroquine, has been floated as a potential candidate. It appears to be able to block viruses from binding to human cells and getting inside them to replicate. It also stimulates the immune system. A letter to the editor in journal Nature on Feb. 4 showed chloroquine was effective in combating SARS-CoV-2. A Chinese study originating from Guangdong reports chloroquine improved patient outcomes and “might improve the success rate of treatment” and “shorten hospital stay.”

Elon Musk, Tesla and SpaceX CEO, and Donald Trump, president of the United States, have both touted chloroquine as a potential treatment candidate. A more recent correspondence in the journal Nature, on March 18, suggests hydroxychloroquine — a less toxic derivative of the drug — is effective at inhibiting SARS-CoV-2 infection. That derivative is widely available to treat disease like rheumatoid arthritis and Chinese researchers have at least seven clinical trials using hydroxychloroquine to treat infection.

The Food and Drug Administration commissioner, Stephen Hahn, discussed the investigations into chloroquine during a White House briefing on March 19. “That’s a drug that the president has directed us to take a closer look at as to whether an expanded use approach to that could be done to actually see if that benefits patients,” said Hahn. Donald Trump announced the FDA approved chloroquine to be used on a “compassionate use” basis on March 19.

However, some researchers think we still need to temper our expectations of these two drugs based on the data we’re currently working with.

“The results are disputed and the clinical trials inconclusive,” says Gaeten Burgio, a medical researcher at Australian National University. “To date there are no clear indications that chloroquine or hydroxychloroquine are a treatment option. Additional clinical trials will tell us whether hydroxychloroquine or chloroquine are viable options for COVID-19 treatments.”

Burgio advises against stockpiling hydroxychloroquine because the drug is critical for treating patients with Lupus.

How you can protect yourself from coronavirus now?

It’s not a good idea to rely on a vaccine to stop the spread of coronavirus because that’s many months away. The best way to stop the spread, right now, is to continue practicing good personal hygiene and to limit interactions with others. “The best thing to do is the simple things like hand washing and hand sanitizing,” Thompson said.

This outbreak is unprecedented, and changing behaviors is absolutely critical to stopping the spread.

There are a huge number of resources available from the WHO on protecting yourself against infection. It’s clear the virus can spread from person to person, and transmission in communities has occurred across the world. Protection boils down to a few key things:

  • Washing your hands: For 20 seconds and no less! You can get some handy handwashing tips here.
  • Maintaining social distancing: Try to keep at least 3 feet (1m) away from anyone coughing or sneezing.
  • Don’t touch your face, eyes or mouth: An incredibly difficult task, but this is how the virus initially gets into the body.
  • Respiratory hygiene measures: Cough and sneeze into your elbow.
  • If you’ve visited a location where COVID-19 is spreading, then self-isolate for 14 days.


  1. I simply want to tell you that I’m beginner to blogging and site-building and certainly loved this web site. Most likely I’m want to bookmark your website . You amazingly have outstanding articles. Appreciate it for sharing with us your blog.

  2. There are some intriguing points in time in this post but I don?t recognize if I see every one of them center to heart. There is some legitimacy yet I will take hold point of view till I check into it better. Good short article, thanks as well as we want much more! Included in FeedBurner also

  3. Well I truly liked reading it. This article provided by you is very practical for good planning.

  4. Hi my loved one! I want to say that this article is awesome, nice written and come with approximately all important infos. I would like to see more posts like this .

  5. There are certainly loads of particulars like that to take into consideration. That could be a nice point to deliver up. I provide the thoughts above as general inspiration but clearly there are questions just like the one you convey up the place the most important thing will likely be working in honest good faith. I don?t know if finest practices have emerged around issues like that, but I am certain that your job is clearly identified as a fair game. Both boys and girls really feel the impact of only a moment’s pleasure, for the remainder of their lives.

  6. It’s hard to find well-informed people on this topic, however, you seem like you know what you’re talking about! Thanks

  7. Do you have a spam problem on this website; I also am a blogger, and I was curious about your situation; many of us have created some nice practices and we are looking to trade techniques with other folks, please shoot me an email if interested.

  8. Odwróć uwagę Jedną z pierwszych rzeczy, które powinieneś zrobić, aby pozbyć się niechcianej erekcji, jest zastanowienie się nad czymś innym. Nie myśl o erekcji i unikaj myślenia pobudzającego myśli. Zamiast tego pomyśl o czymś, co cię rozproszy, na przykład trudne słowo lub problem matematyczny.

  9. The next time I read a blog, I hope that it won’t fail me just as much as this particular one. After all, Yes, it was my choice to read through, nonetheless I really thought you would have something interesting to talk about. All I hear is a bunch of whining about something that you could possibly fix if you weren’t too busy looking for attention.

  10. I just want to mention I am just very new to weblog and actually liked this page. Almost certainly I’m likely to bookmark your blog post . You certainly have outstanding writings. Thank you for sharing with us your blog.

  11. One thing I would like to touch upon is that weightloss system fast may be accomplished by the perfect diet and exercise. Your size not only affects the look, but also the actual quality of life. Self-esteem, depressive disorders, health risks, as well as physical skills are damaged in fat gain. It is possible to do everything right and still gain. Should this happen, a problem may be the reason. While excessive food rather than enough exercise are usually the culprit, common medical ailments and key prescriptions can certainly greatly enhance size. I am grateful for your post right here.

  12. Hi there! Do you know if they make any plugins to assist with Search Engine Optimization? I’m trying to get my blog to rank for some targeted keywords but I’m not seeing very good results. If you know of any please share. Thank you!

  13. Youre so trendy! I don’t mean Ive read anything similar to this before. So good to find someone with some original thoughts on this subject. realy thank you for starting this up. this site is something that is required online, someone with a little creativity. helpful task for bringing something new to the internet!

  14. You’re so cool! I do not think I’ve read a single thing like this before. So great to find somebody with some unique thoughts on this subject. Seriously.. thank you for starting this up. This website is something that’s needed on the internet, someone with a little originality.

  15. A person necessarily assist to make severely posts I’d state. This is the first time I frequented your website page and thus far? I amazed with the research you made to make this actual submit incredible. Magnificent process!

  16. I truly enjoy reading on this website, it has got superb articles. “And all the winds go sighing, For sweet things dying.” by Christina Georgina Rossetti.

  17. There are definitely a great deal of information like that to consider. That is a fantastic point to bring up. I use the thoughts above as basic ideas but plainly there are inquiries like the one you raise where one of the most vital thing will be working in straightforward good faith. I don?t know if finest practices have actually emerged around points like that, but I am sure that your task is plainly recognized as an up for grabs. Both kids as well as girls really feel the effect of just a moment?s enjoyment, for the remainder of their lives.

  18. Howdy! This article could not be written any better! Reading through this post reminds me of my previous roommate! He continually kept talking about this. I will forward this post to him. Fairly certain he’s going to have a great read. Thanks for sharing!

  19. There is visibly a bundle to learn about this. I presume you made certain good points in attributes also.

  20. Everything is very open with a clear clarification of the challenges. It was truly informative. Your site is very helpful. Many thanks for sharing!

  21. I want to to thank you for this fantastic read!! I definitely enjoyed every little bit of it. I’ve got you book marked to check out new stuff you post…

  22. Wreszcie czynniki zależności mogą powodować zaburzenia erekcji. Utrata zainteresowania partnerem może utrudnić uzyskanie erekcji. Kiedy seks staje się obowiązkiem, może również powodować zaburzenia erekcji.

  23. Excellent site you have here.. It’s hard to find good quality writing like yours nowadays. I honestly appreciate individuals like you! Take care!!

  24. Thanks for the helpful write-up. It is also my belief that mesothelioma has an really long latency time period, which means that warning signs of the disease might not exactly emerge right until 30 to 50 years after the 1st exposure to mesothelioma. Pleural mesothelioma, which can be the most common sort and is affecting the area within the lungs, could cause shortness of breath, breasts pains, along with a persistent cough, which may cause coughing up bloodstream.

  25. Good day! I could have sworn I’ve been to this web site before but after looking at a few of the posts I realized it’s new to me. Anyways, I’m certainly happy I found it and I’ll be book-marking it and checking back often.

  26. I really like your blog.. very nice colors & theme. Did you make this website yourself or did you hire someone to do it for you? Plz answer back as I’m looking to create my own blog and would like to find out where u got this from. thank you

  27. Hello.This article was extremely fascinating, particularly since I was searching for thoughts on this topic last couple of days.

  28. I seriously love your website.. Very nice colors & theme. Did you build this web site yourself? Please reply back as I’m looking to create my very own site and would like to find out where you got this from or just what the theme is called. Appreciate it!

  29. Thank you for the sensible critique. Me and my neighbor were just preparing to do a little research on this. We got a grab a book from our area library but I think I learned more from this post. I’m very glad to see such great info being shared freely out there.

  30. Hi! This post could not be written any better! Reading this post reminds me of my previous room mate! He always kept talking about this. I will forward this post to him. Pretty sure he will have a good read. Many thanks for sharing!

  31. After I initially left a comment I seem to have clicked on the -Notify me when new comments are added- checkbox and from now on each time a comment is added I recieve four emails with the exact same comment. Perhaps there is an easy method you can remove me from that service? Thanks a lot.

  32. I seriously love your site.. Excellent colors & theme. Did you develop this amazing site yourself? Please reply back as I’m wanting to create my own site and want to find out where you got this from or exactly what the theme is named. Appreciate it!

  33. Everything is very open with a really clear clarification of the challenges. It was definitely informative. Your website is extremely helpful. Thanks for sharing!

Leave a Reply

Your email address will not be published. Required fields are marked *